Innovex Research Development vs Ebit Analysis

INVX Stock

16.32 0.11 0.68%

Innovex International, financial indicator trend analysis is infinitely more than just investigating Innovex International, recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Innovex International, is a good investment. Please check the relationship between Innovex International, Research Development and its Ebit accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innovex International,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy Innovex Stock please use our How to Invest in Innovex International, guide.

Research Development vs Ebit

Research Development vs Ebit Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Innovex International, Research Development account and Ebit. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Innovex International,'s Research Development and Ebit is 0.5. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Ebit in the same time period over historical financial statements of Innovex International,, assuming nothing else is changed. The correlation between historical values of Innovex International,'s Research Development and Ebit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Innovex International, are associated (or correlated) with its Ebit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit has no effect on the direction of Research Development i.e., Innovex International,'s Research Development and Ebit go up and down completely randomly.

Correlation Coefficient

0.5

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Research Development

Ebit

Most indicators from Innovex International,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Innovex International, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innovex International,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy Innovex Stock please use our How to Invest in Innovex International, guide.Tax Provision is likely to drop to about 7.4 M in 2024. Selling General Administrative is likely to drop to about 64.7 M in 2024

	2021	2022	2023	2024 (projected)
Interest Expense	2.2M	4.0M	4.6M	4.9M
Depreciation And Amortization	17.7M	18.5M	30.5M	27.1M

Interest Expense Depreciation And Amortization

Innovex International, fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Good Will
Total Assets		-0.78	0.58	0.58	1.0	0.97	-0.3	-0.93	0.96	0.07	0.92	0.95	0.88	0.02	0.93	0.82	0.53	-0.74	0.87	0.84	-0.45	0.12	1.0	0.61	0.93	0.27
Short Long Term Debt Total	-0.78		-0.42	-0.4	-0.8	-0.84	0.01	0.8	-0.79	-0.02	-0.77	-0.74	-0.63	0.15	-0.78	-0.62	-0.36	0.94	-0.61	-0.63	0.42	0.19	-0.77	-0.21	-0.84	-0.09
Other Current Liab	0.58	-0.42		0.94	0.52	0.62	-0.13	-0.32	0.38	0.13	0.29	0.39	0.4	0.13	0.29	0.69	0.74	-0.48	0.83	0.6	0.13	0.66	0.62	0.55	0.62	0.42
Total Current Liabilities	0.58	-0.4	0.94		0.52	0.6	-0.06	-0.34	0.4	0.35	0.31	0.45	0.43	0.11	0.32	0.71	0.72	-0.41	0.76	0.49	0.13	0.76	0.61	0.47	0.64	0.38
Total Stockholder Equity	1.0	-0.8	0.52	0.52		0.97	-0.3	-0.95	0.98	0.03	0.94	0.95	0.88	0.03	0.95	0.79	0.5	-0.77	0.84	0.84	-0.49	0.03	0.99	0.6	0.93	0.26
Property Plant And Equipment Net	0.97	-0.84	0.62	0.6	0.97		-0.19	-0.9	0.93	0.02	0.89	0.93	0.9	0.0	0.89	0.78	0.55	-0.79	0.86	0.81	-0.42	0.11	0.96	0.53	0.96	0.28
Current Deferred Revenue	-0.3	0.01	-0.13	-0.06	-0.3	-0.19		0.19	-0.33	-0.09	-0.19	-0.26	-0.13	-0.12	-0.19	-0.36	-0.11	0.09	-0.32	-0.2	0.31	0.04	-0.3	-0.67	-0.09	-0.19
Net Debt	-0.93	0.8	-0.32	-0.34	-0.95	-0.9	0.19		-0.95	0.1	-0.99	-0.93	-0.88	-0.15	-0.99	-0.62	-0.48	0.77	-0.67	-0.71	0.51	0.18	-0.91	-0.48	-0.9	-0.17
Retained Earnings	0.96	-0.79	0.38	0.4	0.98	0.93	-0.33	-0.95		0.06	0.94	0.95	0.87	0.03	0.95	0.76	0.4	-0.75	0.74	0.81	-0.64	-0.09	0.95	0.53	0.88	0.18
Accounts Payable	0.07	-0.02	0.13	0.35	0.03	0.02	-0.09	0.1	0.06		-0.11	0.1	-0.06	-0.38	-0.08	0.42	-0.19	0.15	0.0	-0.1	0.02	0.49	0.07	-0.21	0.04	-0.27
Cash	0.92	-0.77	0.29	0.31	0.94	0.89	-0.19	-0.99	0.94	-0.11		0.93	0.89	0.09	1.0	0.6	0.42	-0.73	0.67	0.71	-0.51	-0.17	0.9	0.47	0.87	0.16
Non Current Assets Total	0.95	-0.74	0.39	0.45	0.95	0.93	-0.26	-0.93	0.95	0.1	0.93		0.92	-0.01	0.94	0.68	0.4	-0.67	0.73	0.69	-0.49	0.03	0.91	0.52	0.89	0.2
Non Currrent Assets Other	0.88	-0.63	0.4	0.43	0.88	0.9	-0.13	-0.88	0.87	-0.06	0.89	0.92		0.08	0.89	0.6	0.41	-0.55	0.69	0.66	-0.46	0.09	0.85	0.44	0.85	0.21
Other Assets	0.02	0.15	0.13	0.11	0.03	0.0	-0.12	-0.15	0.03	-0.38	0.09	-0.01	0.08		0.07	-0.09	0.67	-0.02	0.05	0.09	-0.03	-0.1	0.04	0.36	0.13	0.29
Cash And Short Term Investments	0.93	-0.78	0.29	0.32	0.95	0.89	-0.19	-0.99	0.95	-0.08	1.0	0.94	0.89	0.07		0.61	0.41	-0.73	0.66	0.7	-0.52	-0.17	0.9	0.46	0.88	0.15
Net Receivables	0.82	-0.62	0.69	0.71	0.79	0.78	-0.36	-0.62	0.76	0.42	0.6	0.68	0.6	-0.09	0.61		0.43	-0.52	0.76	0.75	-0.31	0.4	0.85	0.47	0.77	0.07
Common Stock Shares Outstanding	0.53	-0.36	0.74	0.72	0.5	0.55	-0.11	-0.48	0.4	-0.19	0.42	0.4	0.41	0.67	0.41	0.43		-0.5	0.66	0.51	0.07	0.28	0.55	0.64	0.65	0.53
Non Current Liabilities Total	-0.74	0.94	-0.48	-0.41	-0.77	-0.79	0.09	0.77	-0.75	0.15	-0.73	-0.67	-0.55	-0.02	-0.73	-0.52	-0.5		-0.67	-0.68	0.44	0.24	-0.75	-0.4	-0.77	-0.29
Inventory	0.87	-0.61	0.83	0.76	0.84	0.86	-0.32	-0.67	0.74	0.0	0.67	0.73	0.69	0.05	0.66	0.76	0.66	-0.67		0.84	-0.21	0.37	0.89	0.76	0.79	0.56
Other Current Assets	0.84	-0.63	0.6	0.49	0.84	0.81	-0.2	-0.71	0.81	-0.1	0.71	0.69	0.66	0.09	0.7	0.75	0.51	-0.68	0.84		-0.49	0.06	0.87	0.6	0.74	0.31
Other Stockholder Equity	-0.45	0.42	0.13	0.13	-0.49	-0.42	0.31	0.51	-0.64	0.02	-0.51	-0.49	-0.46	-0.03	-0.52	-0.31	0.07	0.44	-0.21	-0.49		0.44	-0.43	-0.22	-0.28	-0.06
Total Liab	0.12	0.19	0.66	0.76	0.03	0.11	0.04	0.18	-0.09	0.49	-0.17	0.03	0.09	-0.1	-0.17	0.4	0.28	0.24	0.37	0.06	0.44		0.14	0.18	0.13	0.17
Total Current Assets	1.0	-0.77	0.62	0.61	0.99	0.96	-0.3	-0.91	0.95	0.07	0.9	0.91	0.85	0.04	0.9	0.85	0.55	-0.75	0.89	0.87	-0.43	0.14		0.63	0.93	0.28
Short Term Debt	0.61	-0.21	0.55	0.47	0.6	0.53	-0.67	-0.48	0.53	-0.21	0.47	0.52	0.44	0.36	0.46	0.47	0.64	-0.4	0.76	0.6	-0.22	0.18	0.63		0.46	0.63
Common Stock	0.93	-0.84	0.62	0.64	0.93	0.96	-0.09	-0.9	0.88	0.04	0.87	0.89	0.85	0.13	0.88	0.77	0.65	-0.77	0.79	0.74	-0.28	0.13	0.93	0.46		0.21
Good Will	0.27	-0.09	0.42	0.38	0.26	0.28	-0.19	-0.17	0.18	-0.27	0.16	0.2	0.21	0.29	0.15	0.07	0.53	-0.29	0.56	0.31	-0.06	0.17	0.28	0.63	0.21

Click cells to compare fundamentals

Innovex International, Account Relationship Matchups

Innovex International, fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.2B	1.2B	284.9M	436.3M	1.0B	1.1B
Other Current Liab	42.2M	35.5M	18.4M	23.4M	42.1M	45.8M
Total Current Liabilities	96.9M	85.5M	69.6M	85.0M	117.7M	87.0M
Total Stockholder Equity	1.1B	1.0B	180.6M	251.3M	881.3M	918.2M
Property Plant And Equipment Net	263.6M	242.0M	37.5M	69.9M	235.1M	237.2M
Current Deferred Revenue	6.9M	11.3M	9.7M	8.0M	7.6M	11.1M
Net Debt	(397.4M)	(344.7M)	25.5M	73.0M	(189.1M)	(198.5M)
Retained Earnings	1.2B	1.1B	8.7M	72.0M	950.7M	858.4M
Accounts Payable	46.3M	37.4M	38.3M	41.7M	65.7M	40.8M
Cash	398.9M	346.0M	9.7M	8.4M	191.4M	265.3M
Non Current Assets Total	326.1M	288.0M	92.0M	153.9M	308.5M	273.5M
Non Currrent Assets Other	13.5M	10.9M	(9.5M)	3.5M	5.8M	8.7M
Cash And Short Term Investments	398.9M	346.0M	9.7M	8.4M	217.3M	266.7M
Net Receivables	248.2M	256.5M	82.7M	126.2M	284.0M	216.8M
Common Stock Shares Outstanding	36.2M	35.3M	35.3M	34.2M	34.5M	30.4M
Liabilities And Stockholders Equity	1.2B	1.2B	284.9M	436.3M	1.0B	1.1B
Non Current Liabilities Total	18.9M	24.1M	34.8M	100.0M	29.2M	19.5M
Inventory	205.1M	212.5M	92.3M	136.7M	194.6M	261.4M
Other Current Assets	28.3M	48.2M	8.2M	11.1M	23.8M	38.8M
Other Stockholder Equity	52.9M	65.6M	169.2M	178.8M	100.3M	92.0M
Total Liab	115.9M	109.6M	104.3M	185.0M	146.9M	139.1M
Total Current Assets	880.5M	863.2M	192.9M	282.4M	719.7M	783.7M
Accumulated Other Comprehensive Income	(143.6M)	(149.7M)	2.5M	318K	(170.1M)	(161.6M)
Short Term Debt	1.5M	1.3M	5.8M	14.7M	2.3M	2.2M
Common Stock	371K	363K	151K	154K	343K	274.0K
Good Will	7.7M	7.9M	16.7M	23.9M	16.7M	17.7M
Intangible Assets	32.1M	29.3M	35.9M	49.8M	41.9M	40.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Innovex Stock Analysis

When running Innovex International,'s price analysis, check to measure Innovex International,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovex International, is operating at the current time. Most of Innovex International,'s value examination focuses on studying past and present price action to predict the probability of Innovex International,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovex International,'s price. Additionally, you may evaluate how the addition of Innovex International, to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Innovex Research Development vs Ebit Analysis

Research Development vs Ebit

Research Development vs Ebit Correlation Analysis

Correlation Coefficient

Research Development

Ebit

Innovex International, fundamental ratios Correlations

Innovex International, Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Innovex International, fundamental ratios Accounts

Also Currently Popular

Additional Tools for Innovex Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 0.99	Total Stockholder Equity
Retained Earnings	+ 0.98	Total Stockholder Equity
Property Plant And Equipment Net	+ 0.97	Total Assets

Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Retained Earnings	- 0.95	Net Debt
Net Debt	- 0.95	Total Stockholder Equity
Non Current Assets Total	- 0.93	Net Debt
Net Debt	- 0.93	Total Assets